BACKGROUND: @entity1358 has shown less response to systemic therapies including chemotherapy, radiation, and immunotherapy than other @entity5 . Surgery has therefore become an important treatment tool. The protocol for treatment is the same for pulmonary metastasis of @entity1358 . We performed surgery for pulmonary metastatic @entity1358 and analyzed the results. MATERIALS AND METHODS: We retrospectively analyzed 15 @entity1 who had undergone pulmonary metastasectomy from @entity1358 at our hospital from January 2005 to December 2009. RESULTS: No @entity1 had extrathoracic metastatsis. The mean age was 60.2 years (range 35~73). There were 12 male and 3 female @entity1 . The number of synchronous and metachronous @entity1 were 8 and 7, respectively. The mean survival times of synchronous and metachronous @entity1 were 32.6 and 42.9 months, respectively. 6 @entity1 had single lesions and 9 @entity1 had multiple (more than 3) lesions. The surgical procedures included wedge resection (10), lobectomy (2), wedge resection with segmentectomy (2), and segmentectomy (1). Median observation and survival time were 54.1 and 34.9 months. The 1-year and 3-year survival rates were 80% and 50%, respectively. CONCLUSION: Pulmonary resection for pulmonary @entity1358 was found to be a safe and effective treatment modality when complete resection was performed.

Surgical resection of pulmonary metastasis from XXXX .

@entity5 :: ('MESH:D009369', 'Disease') :: ['cancers'] @entity1 :: ('9606', 'Species') :: ['patients'] @entity1358 :: ('MESH:D002292', 'Disease') :: ['renal cell carcinomas', 'renal cell carcinoma', 'Renal cell carcinoma', 'metastatic renal cell carcinoma']
@entity1358 :: (MESH:D002292,Disease) :: ['renal cell carcinoma']
